Toxometris.ai
Accelerate your drug design process with cutting-edge in silico toxicity assessment
Toxometris.ai portal is designed to predict the potential toxicity of chemicals and substances using AI based methods. It can help identify potential toxicities at an early stage of drug development, reducing the need for expensive and time-consuming testing in a wet lab. Additionally, Toxometris.ai's in silico toxicity assessment can aid in the prioritization of chemicals for further testing or analysis, saving resources and improving efficiency in research and development.
By predicting toxicity in silico, researchers/industry can focus their efforts on the most promising and least harmful chemicals and substances, which can ultimately lead to safer and more effective products.
The portal supports the following prediction endpoints:
- Genotoxicity/AMES
- Genotoxicity/Micronucleus in vitro
- Genotoxicity/Micronucleus in vivo
- Aqueous solubility
- hERG cardiotoxicity
- Rodent carcinogenicity
- Hepatotoxicity
- The number of endpoints is constantly increasing and eventually will cover almost all ADME and Toxicity.
With the integration of Toxometris.ai and eLabJournal, you can now easily check the physicochemical, biological, and toxic activity of chemical compounds with just a few clicks. The results are highly precise, and you can access them in the dashboard as a PDF report within a short period of time.
